Antisynthetase Syndrome

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Cartesian Therapeutics
1 program
1
Descartes-08Phase 21 trial
Active Trials
NCT07391605Not Yet RecruitingEst. May 2027

Trial Timeline

Clinical trial activity over time

2026
2027
Cartesian TherapeuticsDescartes-08

Clinical Trials (1)

NCT07391605Cartesian TherapeuticsDescartes-08

Descartes-08 in Autoantibody Myositis

Start: Mar 2026Est. completion: May 2027
Phase 2Not Yet Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space